Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates.

Launched by ART FERTILITY CLINICS LLC · Feb 8, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how using special media with antioxidants can help improve the quality of embryos during in vitro fertilization (IVF). The main goal is to see if this antioxidant-enriched environment can increase the chances of embryos being genetically normal (euploid), which is important for successful pregnancies. The trial is currently looking for participants who are undergoing assisted reproductive technology, specifically those who will have intracytoplasmic sperm injection (ICSI) as part of their IVF process.

To be eligible for the study, participants must be between 18 and 43 years old and have enough eggs for the trial. They should also have a body mass index (BMI) of less than 35. Participants will provide both fresh and frozen sperm for the study, but certain conditions, such as specific genetic tests, may exclude some individuals. Those who join the trial can expect to contribute to important research that may help improve outcomes for future IVF treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients undergoing assisted reproductive technology cycles when ICSI is indicated.
• • Patients when Iin vitto fertilization (IVF) is also performed will be included as far as there are enough oocytes for ICSI randomization. However, IVF oocytes will not be used for the study.
• • Maternal age 18-43 years old.
• • PGT-A cycles with only trophectoderm biopsies on day 5/6/7.
• • Patients with more than 6 COCs expected for ICSI.
• • Body mass index \<35.
• • Fresh and frozen ejaculated sperm.
• Exclusion Criteria:
• • PGT-M cycles
• • Fresh and frozen testicular sperm.